232 related articles for article (PubMed ID: 35134624)
21. Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses.
Chen Z; Boon SS; Wang MH; Chan RWY; Chan PKS
J Virol Methods; 2021 Mar; 289():114032. PubMed ID: 33290786
[TBL] [Abstract][Full Text] [Related]
22. Temporal evolution and adaptation of SARS-CoV-2 codon usage.
Posani E; Dilucca M; Forcelloni S; Pavlopoulou A; Georgakilas AG; Giansanti A
Front Biosci (Landmark Ed); 2022 Jan; 27(1):13. PubMed ID: 35090318
[TBL] [Abstract][Full Text] [Related]
23. Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes.
Dilucca M; Forcelloni S; Georgakilas AG; Giansanti A; Pavlopoulou A
Viruses; 2020 Apr; 12(5):. PubMed ID: 32366025
[TBL] [Abstract][Full Text] [Related]
24. Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development.
Wu X; Shan KJ; Zan F; Tang X; Qian Z; Lu J
Adv Sci (Weinh); 2023 Aug; 10(23):e2205445. PubMed ID: 37267926
[TBL] [Abstract][Full Text] [Related]
25. Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization.
Zhao Z; Sokhansanj BA; Malhotra C; Zheng K; Rosen GL
PLoS Comput Biol; 2020 Sep; 16(9):e1008269. PubMed ID: 32941419
[TBL] [Abstract][Full Text] [Related]
26. Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein.
Pal A; Dobhal S; Dey KK; Sharma AK; Savani V; Negi VS
Comput Biol Chem; 2021 Dec; 95():107594. PubMed ID: 34736125
[TBL] [Abstract][Full Text] [Related]
27. Host adaptation of codon usage in SARS-CoV-2 from mammals indicates potential natural selection and viral fitness.
Fu Y; Huang Y; Rao J; Zeng F; Yang R; Tan H; Liu Z; Du W; Liu L
Arch Virol; 2022 Dec; 167(12):2677-2688. PubMed ID: 36166106
[TBL] [Abstract][Full Text] [Related]
28. The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense.
Azgari C; Kilinc Z; Turhan B; Circi D; Adebali O
Viruses; 2021 Mar; 13(3):. PubMed ID: 33801257
[TBL] [Abstract][Full Text] [Related]
29. Genomic Analyses of Major SARS-CoV-2 Variants Predicting Multiple Regions of Pathogenic and Transmissive Importance.
Brugger SW; Grose JH; Decker CH; Pickett BE; Davis MF
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400051
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes.
Jungreis I; Sealfon R; Kellis M
Nat Commun; 2021 May; 12(1):2642. PubMed ID: 33976134
[TBL] [Abstract][Full Text] [Related]
31. Phylogenetic and phylodynamic analyses of SARS-CoV-2.
Nie Q; Li X; Chen W; Liu D; Chen Y; Li H; Li D; Tian M; Tan W; Zai J
Virus Res; 2020 Oct; 287():198098. PubMed ID: 32687861
[TBL] [Abstract][Full Text] [Related]
32. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.
Laamarti M; Alouane T; Kartti S; Chemao-Elfihri MW; Hakmi M; Essabbar A; Laamarti M; Hlali H; Bendani H; Boumajdi N; Benhrif O; Allam L; El Hafidi N; El Jaoudi R; Allali I; Marchoudi N; Fekkak J; Benrahma H; Nejjari C; Amzazi S; Belyamani L; Ibrahimi A
PLoS One; 2020; 15(11):e0240345. PubMed ID: 33170902
[TBL] [Abstract][Full Text] [Related]
33. Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications.
Yin C
J Theor Biol; 2021 Apr; 515():110604. PubMed ID: 33508323
[TBL] [Abstract][Full Text] [Related]
34. Cross-species transmission of the newly identified coronavirus 2019-nCoV.
Ji W; Wang W; Zhao X; Zai J; Li X
J Med Virol; 2020 Apr; 92(4):433-440. PubMed ID: 31967321
[TBL] [Abstract][Full Text] [Related]
35. A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.
Saha J; Bhattacharjee S; Pal Sarkar M; Saha BK; Basak HK; Adhikary S; Roy V; Mandal P; Chatterjee A; Pal A
Gene Rep; 2021 Jun; 23():101055. PubMed ID: 33615042
[TBL] [Abstract][Full Text] [Related]
36. Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design.
Sheikh A; Al-Taher A; Al-Nazawi M; Al-Mubarak AI; Kandeel M
J Virol Methods; 2020 Mar; 277():113806. PubMed ID: 31911390
[TBL] [Abstract][Full Text] [Related]
37. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.
Tan Y; Schneider T; Leong M; Aravind L; Zhang D
mBio; 2020 May; 11(3):. PubMed ID: 32471829
[TBL] [Abstract][Full Text] [Related]
38. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
[TBL] [Abstract][Full Text] [Related]
39. Characterization of accessory genes in coronavirus genomes.
Michel CJ; Mayer C; Poch O; Thompson JD
Virol J; 2020 Aug; 17(1):131. PubMed ID: 32854725
[TBL] [Abstract][Full Text] [Related]
40. Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations.
Dimonaco NJ; Salavati M; Shih BB
Viruses; 2020 Dec; 13(1):. PubMed ID: 33396801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
